ALS Centre Netherlands schedules all diagnostic research and consultations for each patient on one day. A large majority of around 90% of all Dutch ALS patients are diagnosed at ALS Centre Netherlands. In total, more than 500 patients are diagnosed with ALS, PLS, PMA or one of its mimics each year. Prof. Leonard van den Berg, director of the ALS Centre Netherlands is one of the initiators of the TRICALS platform with the aim to speed up the research for a treatment for ALS by increased collaboration between patients, the industry and ALS centres. He is also one of the initiators of Project Mine (www.projectmine.com), the largest research of the genetic basis of ALS worldwide. Additionally, the research focuses on epidemiology, brain imaging and cognitive functioning of ALS patients.
Leonard van den BergProfessor of Neurology
Professor Leonard van den Berg is professor of Neurology and coordinator of the ALS Centre Netherlands.
TUDCA (tauroursodeoxycholic acid) is a small molecule that is being explored for its potential as a treatment for ALSRead more
PreLude (Lithium carbonate)
Within an innovative platform design study, we will evaluate the efficacy of lithium carbonate in UNC13a homozygous patients.Read more
Within an innovative platform design study, we will evaluate the efficacy of Triumeq, a therapy developed for treatment of HIV that has shown to slow progression in ALSRead more
iAdore (Oral edaravone)
Within an innovative platform design study, we will evaluate the efficacy of oral edaravone (TW001), a formulation that reduces oxidative stressRead more